Centrum Medyczne Pratia Gdynia

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Graves' disease and hyperthyroidism2 trials
• Obesity2 trials
• Osteoporosis2 trials
• Rheumatoid arthritis1 trial
• Ulcerative colitis1 trial

Phase

• Phase 39 trials
• Phase 41 trial

Status

• Completed8 trials
• Active, not recruiting2 trials

Lead sponsor

• Novo Nordisk A/S3 trials
• Viridian Therapeutics, Inc.2 trials
• Abivax S.A.1 trial
• Alfasigma S.p.A.1 trial
• Enzene Biosciences Ltd.1 trial
• and 2 more

Running trials

• Active, not recruiting

  A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

  NCT06812325· Phase 3· Viridian Therapeutics, Inc.· Source

• Active, not recruiting

  An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

  NCT06625398· Phase 3· Viridian Therapeutics, Inc.· Source

Closed trials

• Completed

  The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the trial around the participant, known as decentralised, and hybrid clinical trials compared to standard clinical trials that take place in hospitals or in research centres, in patients with type 2 diabetes mellitus treated with Toujeo®, a drug to help manage blood sugar levels.

  2022-500449-26-00· Phase 4· University Medical Center Utrecht· Source

• Completed

  ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

  NCT05507216· Phase 3· Abivax S.A.· Source

• Completed

  A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

  NCT05649137· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)

  NCT05646706· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

  NCT05405725· Phase 3· Enzene Biosciences Ltd.· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

  NCT05013229· Phase 3· Novo Nordisk A/S· Source

• Completed

  Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

  NCT05087030· Phase 3· Gedeon Richter Plc.· Source

• Completed

  Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

  NCT03025308· Phase 3· Alfasigma S.p.A.· Source